Max Healthcare Institute's Q2 FY 2025-26 Quarterly Results
- 16 Nov 2025
Result Summary
- Max Healthcare Institute Ltd reported a 5.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 24.0%.
- Its expenses for the quarter were up by 3.5% QoQ and 25.3% YoY.
- The net profit increased 59.5% QoQ and increased 74.3% YoY.
- The earnings per share (EPS) of Max Healthcare Institute Ltd stood at 5.02 during Q2 FY 2025-26.
Financial Statments for Q2 FY 2025-26
Total Income | 2168.37 | 2064.08 | 1748.30 | 5.1% | 24.0% |
Total Expenses | 1722.34 | 1663.65 | 1374.61 | 3.5% | 25.3% |
Profit Before Tax | 446.03 | 400.43 | 373.69 | 11.4% | 19.4% |
Tax | -45.27 | 92.46 | 91.88 | -149.0% | -149.3% |
Profit After Tax | 491.30 | 307.97 | 281.81 | 59.5% | 74.3% |
Earnings Per Share | 5.02 | 3.15 | 2.88 | 59.4% | 74.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Max Healthcare Institute Ltd is a prominent player in the healthcare industry, primarily engaged in providing healthcare services. The company operates a network of hospitals and healthcare facilities across various regions, offering a wide range of medical services, including diagnostics, treatment, and surgeries. As of the latest update available, Max Healthcare has been focusing on expanding its service offerings and improving patient care quality. However, specific details about recent major developments or strategic initiatives were not provided in the available data.
Revenue
In Q2FY26, Max Healthcare Institute Ltd reported a total income of ₹2168.37 crores, marking a 5.1% increase from the previous quarter (Q1FY26) where the total income was ₹2064.08 crores. When compared to Q2FY25, the total income rose by 24.0%, indicating a substantial year-over-year increase from ₹1748.30 crores. These figures suggest a positive trend in the company's revenue generation over the past year, reflecting growth in its healthcare services and operations.
Profitability
The company's profit before tax (PBT) for Q2FY26 amounted to ₹446.03 crores, showing an 11.4% increase from the previous quarter's PBT of ₹400.43 crores. Compared to the same quarter in the previous year (Q2FY25), the PBT increased by 19.4% from ₹373.69 crores. Notably, the profit after tax (PAT) for Q2FY26 was ₹491.30 crores, significantly higher than the PAT of ₹307.97 crores in Q1FY26, representing a 59.5% quarter-over-quarter increase. Year-over-year, the PAT grew by 74.3% from ₹281.81 crores in Q2FY25. This substantial increase in PAT can be attributed to tax adjustments, as indicated by the negative tax value in Q2FY26.
Operating Metrics
Earnings per share (EPS) for Q2FY26 stood at ₹5.02, compared to ₹3.15 in Q1FY26, reflecting a 59.4% increase quarter-over-quarter. Year-over-year, the EPS rose by 74.3% from ₹2.88 in Q2FY25. Total expenses for the quarter amounted to ₹1722.34 crores, up by 3.5% from ₹1663.65 crores in the previous quarter and showing a 25.3% increase from ₹1374.61 crores in Q2FY25. These metrics indicate that while the company experienced growth in its revenue and profitability, there was also a corresponding increase in its operating expenses.